About Treatment

The NerveStim® Neuropathy System

The NerveStim® Neuropathy System combines two breakthrough technologies into one unmatched solution: the Hemastyl® wound gel and the NerveStim NMES Device. Together, they create a wound-healing system so effective that no competing product in the market even comes close. Hemastyl® forms the essential first layer, applied directly to the device’s medical-grade surface. Once the NerveStim is placed around the wound, the system delivers targeted neuromuscular stimulation designed to accelerate closure, enhance circulation, and support tissue recovery in ways traditional dressings simply cannot.

Clinicians and providers finally have access to a tool that is fast, consistent, and built for real-world outcomes. Treatment using the NerveStim® Neuropathy System is eligible for Medicare, Medicaid, and many private insurance reimbursements, making advanced care accessible to more patients without added burden to facilities.

Product Information

Key Features

The NerveStim Neuropathy system is a category-defining technology that sets a new standard for healing performance and clinical efficiency—and the results speak for themselves. Designed to accelerate healing, improve circulation, and promote tissue regeneration—outperforming traditional wound care modalities and all competing products.

Neuropathy Healing

Combines the proprietary FDA-approved Hemastyl formulation with our NerveStim NMES device to directly address the underlying nerve dysfunction while supporting the body’s natural healing pathways. 

Versatile Indications and Wound-type Compatibility

In a feasibility study, Hemastyl prevented 17 amputations and closed 39 total complex wounds. This was accomplished by treating the tissue surrounding the wound, preventing scheduled amputations from ever taking place.

99% effective against CANDIDA AURIS

Proven effective against Candida Auris, a deadly candida organism that is spreading in hospitals around the globe. This organism has been proving to be antibiotic resistant and all current antifungal medications are not effective against this strain, according to the CDC.

Hydrogel Base for Moist Wound Healing Environment

Amorphous hydrogel formulation supports moisture donation, hydration of wound bed and helps maintain a moist environment conducive to healing. Integrates seamlessly into daily wound-care routines.

Versatile Indications and Wound-type Compatibility

In a feasibility study, Hemastyl prevented 17 amputations and closed 39 total complex wounds. This was accomplished by treating the tissue surrounding the wound, preventing scheduled amputations from ever taking place.

99% effective against CANDIDA AURIS

Proven effective against Candida Auris, a deadly candida organism that is spreading in hospitals around the globe. This organism has been proving to be antibiotic resistant and all current antifungal medications are not effective against this strain, according to the CDC.

Real Case Progressions

Clinical Case Timelines From Real Use

These examples show how the NerveStim Neuropathy System has been used in real clinical settings to support healing in challenging wounds. Each timeline reflects the patient’s individual course under physician care. Images are shared with permission.

Science

Common Hemastyl wound gel use in wound care

Pressure injuries: Hemastyl gel can be used with all stages of pressure injuries. Due to its antimicrobial benefits, it is a good option for infected wounds as well as pressure injuries, such as wounds on the tailbone or buttocks.

Venous ulcers: The use of Hemastyl gel on venous stasis ulcers is less common due to the risk of overhydrating the wound and macerating the periwound. Since venous stasis ulcers are commonly higher output wounds, take care when using a wound hydrating treatment.

Arterial ulcers: This ulcer etiology typically has a dryer wound bed with no to minimal drainage. This makes the choice to use Hemastyl gel appropriate for open arterial ulcers. As always, protect and keep stable dry eschar on heels and toes to prevent infection and wound deterioration until a vascular specialist evaluates the patient.

Diabetic wounds: You can use this treatment on neuropathic wounds, such as diabetic foot ulcers, which often have some level of arterial involvement as a secondary cause. With these wounds, be mindful of dry eschar on the heel and toes (like with arterial ulcers) until the patient undergoes a thorough vascular assessment.

Traumatic wounds: Hemastyl gel can be beneficial on traumatic wounds as it can decrease pain in the wound bed. Keeping the wound bed moist with frequent dressing changes and a hydrating gel can decrease pain and make dressing changes a faster and more comfortable process. The antimicrobial preservation property of Hemastyl gel is an added bonus for patients.

Latest News

Read Latest News

This section features updates from our team, insights on product development, and announcements as Hemastyl® progresses through clinical, regulatory, and commercial milestones. Stay connected as we share news, company developments, and future resources designed to support clinicians and patients alike.

Citeline: Rapid Nexus Bets On Regeneration To Heal Wounds, Stop Amputations, Starting In VA Health Systems

Rapid Nexus hopes its regenerative wound-healing system can ease the burden of diabetic foot ulcers and amputations. Backed by early clinical data and $3.8m in seed funding, the start-up is targeting...

Yahoo Finance: Rapid Nexus Unveils First-Ever Medical Technology to Regrow Nerves and Stop Amputations in Diabetic Patients

This patented breakthrough is the first and only technology to treat dying tissue and regenerate nerves — restoring circulation, reversing chronic wounds, and preventing amputations for patients who...

Rapid Nexus Clinches 1st Place at PitchForce

Dr. Margaret Kalmeta was handpicked by a panel of seasoned investors as the 1st-place winner at PitchForce, where she delivered a compelling 4-minute pitch on Rapid Nexus Nanotech Wound Solutions...